The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression by Zhang, X. et al.
association of RBPs with GREs ultimately
determines the half-life of the mRNA and/
or its translation. Within the framework of
the study, it will also be interesting to in-
vestigate whether T cell activation affects
the interaction of CUGBP1 and GRE-con-
taining mRNAs: do RNP complexes in-
crease, decrease, or change subcellular
location? Broader questions center on
the elucidation of the degradation ma-
chineries responsible for the breakdown
of GRE-containing mRNAs: Are the
exosome, the proteasome, or processing
bodies implicated or is there a special-
ized GRE-mRNA-degrading apparatus?
Is CUGBP1-triggered deadenylation re-
quired for the decay of GRE-containing
mRNAs?
As examples accumulate of both ARE-
bearing stable mRNAs and labile mRNAs
lacking AREs, the ARE dogma has incre-
mentally given way to alternative bona
fide instability sequences. In this context,
the novel GRE degradation motif identi-
fied by Vlasova et al. (2008) provides the
fast-advancing field of accelerated
mRNA decay with broader insight into
the nature of turnover determinants. With
an increasing understanding of mRNA
regulatory elements and the mRNA-bind-
ing factors (RBPs, microRNAs) that inter-
act with them, the 30UTR emerges as an
ever richer platform from which to govern
gene expression.
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In a recent issue of Molecular Cell, two independent studies (Zhang et al., 2008; Zhao et al., 2008) provide
compelling evidence that targeted deubiquitylation of histones is intimately linked to transcription activation,
epigenetic regulation, and cancer progression.The yeast SAGA coactivator complex has
served as a paradigm for the interconnec-
tion between chromatin modification and
the transcriptional status of genes (Lee
and Workman, 2007). A plethora of ge-
netic and biochemical studies showed
that SAGA connects gene-specific activa-
tor proteins, the basal RNA polymerase
II-transcription machinery, and histone
acetylation, which represents an activat-
ing chromatin mark (Berger, 2007). More
recently, yeast SAGA was shown to har-
bor the Ubp8p deubiquitylase (DUB) en-
zyme (Berger, 2007). Two recent studies
on the metazoan orthologs provide new
insight into histone crosstalk.152 Molecular Cell 29, February 1, 2008 ª20The multigroup effort headed by Didier
Devys identifies three new subunits of the
TFTC/STAGA complexes in Drosophila
melanogaster and in human cells (Zhao
et al., 2008) and an overall composition
that is very similar to yeast SAGA. There-
fore, we believe that it is timely to aban-
don the ‘‘old’’ TFTC/STAGA/PCAF names
now and to embrace SAGA as the
descriptor for orthologous complexes
in other organisms. The three new SAGA
subunits are human USP22 (Ubp8p in
yeast or Nonstop in flies), ATXN7L3
(ySfg11p or dSgf11), and ENY2 (ySus1p
or dE[y]2). Zhao et al. (2008) show that
the new members form a SAGA submod-08 Elsevier Inc.ule with TAF5L and ATXN7. Purified
human SAGA, but not the recombinant
submodule, can remove ubiquitin effi-
ciently both from histone H2A and H2B
in vitro. Whereas monoubiquitylated H2B
(H2Bub1) is linked to transcription elonga-
tion (Wyce et al., 2007) and is required for
methylation of K4 and K79 of histone H3 in
yeast, H2Aub1 is metazoan specific and
formed by the action of Polycomb repres-
sive complex 1 (PRC1), a regulator of fac-
ultative heterochromatin (Berger, 2007).
Using the position effect variegation (PEV)
assay for facultative heterochromatin in
fruit flies, they find that dNonstop and
dSgf11 mutations enhance the variegated
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PreviewsFigure 1. Model for DUB Action in Gene Activation
Model describing the possible interplay of histone modifications around USP22 and H2A monoubiquitylation relevant for transcriptional repression (A) or activa-
tion (B). Angled arrows indicate enzymatic activity. Double-headed arrows depict binding activity.phenotype indicative of white gene re-
pression, whereas dNonstop overexpres-
sion activates transcription. Interestingly,
the PEV function does not require the
dNonstop ZnF domain, which is essential
for USP22 integration into SAGA. Addi-
tional experiments show that both hSAGA
and dSAGA can be recruited to promoters
by the androgen receptor (AR) and that full
activation of AR target genes is regulated
by hUSP22 and dNonstop expression.
The starting point for the other study
(Zhang et al., 2008) was the identification
of the USP22 ubiquitin hydrolase as
a part of a cancer stem cell signature,
which also includes two Polycomb group
members, BMI-1 and RNF2/Ring1b. Inter-
estingly, BMI-1 and RNF2/Ring1b form
the E3 ligase that directs H2A ubiquityla-
tion. Using conditional expression of the
c-myc and p53 transcriptional activators,
Zhang et al. (2008) find that USP22 knock-
down reduces transcriptional activation of
all c-myc and of most p53 target genes
tested. As expected for a ‘‘true’’ coacti-
vator, USP22 recruitment to target pro-
moters depends on c-myc, but c-myc
recruitment is not dependent on USP22.
Knockdown of USP22 compromises cell-
cycle progression and anchorage-inde-
pendent growth, which strengthens the
link with cancerous growth. By epitope
tagging, Zhang et al. (2008) also find that
USP22 is stably associated with multiple
subunits of SAGA and that USP22-puri-
fied SAGA can both acetylate histonesand deubiquitylate H2Bub1 in vitro. Al-
though they did not test H2Aub1 as a sub-
strate, this was clearly demonstrated by
Zhao et al. (2008). Unfortunately, neither
study tested ubiquitylated nucleosomes
as DUB substrates. USP22 might have
a broad substrate specificity, as its initial
characterization (Lee et al., 2006) showed
that it can also utilize an artificial substrate
(ubiquitin/b-galactosidase fusion).
These two papers put histone (de)-
ubiquitylation in the spotlight of epige-
netics and cancer biology and have
important ramifications for follow-up
studies. Important questions for USP22
and other histone DUBs (Nakagawa
et al., 2008; van der Knaap et al., 2005)
include the following:
 How can histone substrate specific-
ity of DUBs be validated in vivo?
 Do histone DUBs have additional
substrates relevant for chromatin
and transcription?
 How are the DUBs targeted to chro-
matin loci?
 How are the H2Aub1 and H2Bub1
marks ‘‘read’’?
For USP22, several observations indi-
cate that targeting occurs via SAGA
recruitment. However, the PEV function
of USP22 does not seem to require
SAGA incorporation (Zhao et al., 2008).
Possibly, this DUB can also act outside
of its SAGA context. The fact that
USP22 is the only SAGA subunit in theMolecular Cell 2cancer stem cell signature hints at this
possibility. Related to the DUB specificity
question is identification of protein (com-
plexes) ‘‘reading’’ the ubiquitin-histone
code. Although no direct binders of
H2Aub1 or H2Bub1 have been identified
yet, recent data show that H2Aub1 recon-
stituted chromatin is a poor template for
in vitro transcription (Nakagawa et al.,
2008), which might relate to the inability
of the histone H3K4 methyltransferase
MLL3 (also called KMT2C) to use H2Aub1
nucleosomes.
Together with this finding, the two new
studies (Zhang et al., 2008; Zhao et al.,
2008) suggest that crosstalk between his-
tone modifications like H3 methylation/
acetylation and H2Aub1 could depend
on the interplay between the Polycomb
group, SAGA, and MLL3(KMT2C)/
MLL4(KMT2D) histone-modifying com-
plexes (Figure 1). To maintain the tran-
scriptionally repressed state, the PRC1
and PRC2 complexes ubiquitylate H2A
at K119 and trimethylate H3 at K27, re-
spectively. These modifications prevent
H3K4 methylation (Nakagawa et al.,
2008) and acetylation at H3K27. Signal-
dependent activation by sequence-spe-
cific transcription activators would recruit
SAGA to remove ubiquitin from histones
via USP22. This action would allow the
MLL complexes to trimethylate H3K4,
which stabilizes TFIID binding via the
TAF3-PHD (Vermeulen et al., 2007). The
MLL3/MLL4 complexes also harbor9, February 1, 2008 ª2008 Elsevier Inc. 153
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PreviewsH3K27 demethylases (Rivenbark and
Strahl, 2007), and would liberate H3K27
for subsequent SAGA-dependent acety-
lation. In this pathway SAGA not only
plays a pivotal role in gene induction but
also collaborates with MLL complexes
to counter Polycomb-mediated repres-
sion and to maintain gene expression pro-
grams relevant for cancer via epigenetic
mechanisms.
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GATA-1 and GATA-2 control prolife
tional regulation. In this issue of Mo
the Kit locus directs a transcription
Hematopoiesis is a classical model sys-
tem to study the regulation of gene expres-
sion during development and differentia-
tion. During differentiation, hematopoietic
stem cells progressively lose their self-re-
newal capacity and mature to specialized
blood cells that produce specific proteins,
including the hemoglobins. The GATA
family of transcription factors is made of
key regulators of hematopoiesis; they reg-
ulate the expression of genes involved
both in the proliferation of progenitor cells
and their differentiation to mature blood
cells (Cantor and Orkin, 2005; Kim and
Bresnick, 2007). GATA-1 is critical for
terminal differentiation and maturation of
progenitor cells, whereas GATA-2 is re-
quired for the maintenance and prolifera-
tion of the hematopoietic progenitor cells.
Furthermore, both factors are positively
autoregulated, GATA-1 represses the ex-
pression of GATA-2, whereas GATA-2
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ece
ration and differentiation of hematop
lecular Cell, Jing et al. (2008) demons
al switch by reconfiguring chromatin
activates GATA-1 expression, thus provid-
ing evidence for a regulatory network of
GATA factors controlling hematopoiesis
(Ferreira et al., 2005).
GATA-1 and GATA-2 possess similar in-
trinsic abilities to bind GATA sites and inter-
act with other transcriptional regulatory
proteins, (e.g., nucleosome modifiers, co-
factors, etc.), including the specialized
GATA cofactor FOG-1 (Rodriguez et al.,
2005).GATA-FOG-1 interactionsarecritical
for GATA function in vivo, but their mecha-
nism of action remains unknown. In addi-
tion, FOG-1 bound to GATA factors can
have opposite effects in regulation of tran-
scription (i.e., activation versus repression)
in different promoter and enhancer con-
texts (Cantor and Orkin, 2005). Most likely,
the geometryof the GATA-FOG-1complex,
when bound to different sites, is influenced
by the precise DNA sequence and/or by
nearby factors. Therefore, the complex
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oietic progenitor cells via transcrip-
trate that GATA factor exchange on
loops.
might undergo allosteric changes, lead-
ing to the recruitment of coactivator or
corepressor complexes. The hallmark of
GATA-1 and other erythroid-specific tran-
scription factor (e.g., EKLF) function during
erythropoiesis is their involvement in the
formation of chromatin loops between the
remote globin enhancer (locus control re-
gion [LCR]) and individual globin gene pro-
moters in a competitive manner (Vakoc
et al., 2005). These chromatin loops are
formed between the LCR and the relevant
globin gene in a developmentally regulated
manner and have been correlated with
gene activation. However, it remains un-
clear whether chromatin loops supporting
the expression of a gene can be reconfig-
ured when this gene is turned off and what
the role, if any, is of transcription factors in
specialized chromatin loop configurations.
In this issue of Molecular Cell, Jing et al.
(2008) provide the first evidence for how
